Jaguar Health, Inc.(JAGX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Jaguar Health, Inc. (JAGX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores JAGX at 12.8/100 on a 32-signal composite quality model, placing it at rank #2,846 of 2,884 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (1.4) and balance sheet strength (2.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Jaguar Health, Inc. reports quarterly revenue of $1.2M, net income of $-12.8M. Top institutional holders of JAGX by reported 13-F value include UBS Group AG, Tower Research Capital (TRC), SBI Securities , Ltd., based on the most recent SEC filings. JAGX trades on the Nasdaq exchange and files with the SEC under CIK 1585608. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate JAGX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Jaguar Health, Inc. directly from SEC EDGAR.